Gelion plc announced the appointment of Dr. Louis Adriaenssens as Chief Technological Officer (CTO) of the company and Dr. Adrien Amigues as President of Gelion UK and Europe, with immediate effect. Louis joins Gelion with exceptional experience in specialist battery innovation, manufacture and commercialisation, having most recently worked in Nevada as the Supervisor of Chemistry for Panasonic at the Tesla Gigafactory, where he and his team looked after the processes associated with the production of approximately 5 million battery cells per day. A contributing author/inventor of leading scientific articles and significant patents across the fields of materials chemistry, electrochemistry and synthesis, Louis will lead a technical team of over 20 PhD or graduate level engineers and scientists, across Australia and the UK stewarding a portfolio including 470 patents in 76 patent families (including new patents under application).

The appointment of a CTO comes at a pivotal time in the development of Gelion's Lithium-Sulfur (LiS) and Zinc-based (Zn) battery technologies and operational expansion into the UK and Europe. This follows the acquisition of OXLiD Ltd. in November 2023, whose founder Dr. Adrien Amigues will now take up the role of President of Gelion UK and Europe. Gelion founder and Principal Technology Adviser, Professor Thomas Maschmeyer, will continue with all his leadership contributions and governance roles within the Group.